Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 18070-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- SEMA7A antibody
- Antibody type
- Polyclonal
- Description
- SEMA7A antibody (Cat. #18070-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references NCAPG promotes the malignant progression of endometrioid cancer through LEF1/SEMA7A/PI3K-AKT.
Ceria nanoparticles guard against glucocorticoid induced bone homeostasis imbalance through the promotion of osteogenesis and inhibition of osteoclastogenesis.
Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer.
Sema7A protects against high-fat diet-induced obesity and hepatic steatosis by regulating adipo/lipogenesis.
EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer.
Kruppel-like factor 13 inhibits cell proliferation of gastric cancer by inducing autophagic degradation of β-catenin.
Ren Z, Li X, Fu C
Journal of Cancer 2025;16(2):445-459
Journal of Cancer 2025;16(2):445-459
Ceria nanoparticles guard against glucocorticoid induced bone homeostasis imbalance through the promotion of osteogenesis and inhibition of osteoclastogenesis.
Zhang A, Liu Z, Zou L, Yang L, Wu Y, Wang X, Cao D, Liu J, Yang X, Zhang S
Materials today. Bio 2025 Dec;35:102308
Materials today. Bio 2025 Dec;35:102308
Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer.
Tan X, Wang S, Xiao GY, Wu C, Liu X, Zhou B, Jiang Y, Duose DY, Xi Y, Wang J, Gupta K, Pataer A, Roth JA, Kim MP, Chen F, Creighton CJ, Russell WK, Kurie JM
The Journal of clinical investigation 2024 Apr 25;134(12)
The Journal of clinical investigation 2024 Apr 25;134(12)
Sema7A protects against high-fat diet-induced obesity and hepatic steatosis by regulating adipo/lipogenesis.
Lu Q, Liu Z, Zhao L, Xu L, Liu C, Li L, Cao Y, Li F, Wu L, Wang L, Chen T, You T, Ren L, Wang G, Tang C, Zhu L
Molecular metabolism 2023 Apr;70:101698
Molecular metabolism 2023 Apr;70:101698
EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer.
Tan X, Xiao GY, Wang S, Shi L, Zhao Y, Liu X, Yu J, Russell WK, Creighton CJ, Kurie JM
The Journal of clinical investigation 2023 Apr 3;133(7)
The Journal of clinical investigation 2023 Apr 3;133(7)
Kruppel-like factor 13 inhibits cell proliferation of gastric cancer by inducing autophagic degradation of β-catenin.
Ding Y, Xu Y, Fu Y, Zhang H, Zhao L, Fan X
Discover oncology 2022 Nov 6;13(1):121
Discover oncology 2022 Nov 6;13(1):121
No comments: Submit comment
No validations: Submit validation data